ImmunoVaccine Technologies Inc.

9 records totalling $8,660,951.00 CAD, from official Government of Canada open data.

Embed this chart

By department

Records

Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique
Atlantic Innovation Fund (AIF) - II
FY 2008-2009
Canada

Evaluate Novel Adjuvant Systems in VacciMax

Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique
Atlantic Innovation Fund (AIF) - II
FY 2011-2012
Canada

Development of DepoVax-based cancer immunotherapies

Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique
REGI - Business Scale-up and Productivity
FY 2020-2021
Canada

Support pre-clinical development activities for COVID-19 vaccine

Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique
REGI - Business Scale-up and Productivity
FY 2020-2021
Canada

Support pre-clinical development activities for COVID-19 vaccine

Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique
Business Development Program
FY 2014-2015
Canada

Facilitate a GMP clinical vaccine manufacture

Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique
Business Development Program
FY 2008-2009
Canada

Undertake marketing activities

Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique
Business Development Program
FY 2010-2011
Canada

Commercialization and business development activities

Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique
BDP - Productivity and Business Skills
FY 2009-2010
Canada

Hire a senior research scientist

Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique
BDP - Productivity and Business Skills
FY 2008-2009
Canada

Hire a consultant